loadpatents
name:-0.050045013427734
name:-0.0042221546173096
name:-0.0018260478973389
Morris; Shannon Renae Patent Filings

Morris; Shannon Renae

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morris; Shannon Renae.The latest application filed is for "combination".

Company Profile
1.5.17
  • Morris; Shannon Renae - Research Triangle Park NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination
App 20200222431 - Cornfeld; Mark J. ;   et al.
2020-07-16
Enzalutamide In Combination With Afuresertib For The Treatment Of Cancer
App 20180344699 - Kumar; Rakesh ;   et al.
2018-12-06
Combination
App 20180264008 - Cornfeld; Mark J. ;   et al.
2018-09-20
Combination
App 20180214451 - Dumble; Melissa ;   et al.
2018-08-02
Enzalutamide In Combination With Afuresertib For The Treatment Of Cancer
App 20180117011 - KUMAR; Rakesh ;   et al.
2018-05-03
Combination
App 20170239274 - CORNFELD; Mark J. ;   et al.
2017-08-24
Enzalutamide In Combination With Afuresertib For The Treatment Of Cancer
App 20160235714 - KUMAR; Rakesh ;   et al.
2016-08-18
Combination
App 20160228456 - CORNFELD; Mark J. ;   et al.
2016-08-11
Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer
Grant 9,402,846 - Dumble , et al. August 2, 2
2016-08-02
Combination
App 20160143913 - Dumble; Melissa ;   et al.
2016-05-26
Combination
App 20150094321 - DUMBLE; Melissa ;   et al.
2015-04-02
Combination
App 20140350039 - DUMBLE; Melissa ;   et al.
2014-11-27
Combination
App 20140309243 - DUMBLE; Melissa ;   et al.
2014-10-16
Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer
Grant 8,835,450 - Dumble , et al. September 16, 2
2014-09-16
Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarbo
Grant 8,796,298 - Dumble , et al. August 5, 2
2014-08-05
Combination
App 20120283278 - Dumble; Melissa ;   et al.
2012-11-08
Combination
App 20120245180 - Auger; Kurt R. ;   et al.
2012-09-27
Combination
App 20120202822 - Bachman; Kurtis Earl ;   et al.
2012-08-09
Combination
App 20120202835 - Dumble; Melissa ;   et al.
2012-08-09
Combination
App 20120196886 - Dumble; Melissa ;   et al.
2012-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed